Medautonomic Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Medautonomic General Information


Developer of a brain neuromodulator intended to send a precise signal to the brain. The company offers a device that provides an alternative method of neuromodulation than gastric pacing to address digestive functional diseases including obesity, gastro-esophageal reflux disease, and high resting heart rate, enabling medical professionals to easily treat metabolic syndrome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Corporate Office
  • 1235 Traud Drive
  • Concord, CA 94518
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medautonomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 19-Sep-2016 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jun-2015 00.000 00.000 000.00 Completed Generating Revenue
To view Medautonomic’s complete valuation and funding history, request access »

Medautonomic Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
To view Medautonomic’s complete cap table history, request access »

Medautonomic Patents

Medautonomic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220008099-A1 Implanting system for implanting a totally implantable device in a human or animal body Pending 14-Nov-2018 00000000000 0
EP-3852657-A1 Implanting system for implanting a totally implantable device in a human or animal body Inactive 14-Nov-2018 00000000000
US-20220007924-A1 Endoscope with an endoscope support comprising a telescopic rod and a ball joint Pending 25-Oct-2018 00000000000 0
EP-3849393-A1 Endoscope with an endoscope support comprising a telescopic rod and a ball joint Inactive 25-Oct-2018 00000000000
US-20200297380-A1 Implantation tool for implanting a totally implantable device in the body of a human or animal Active 18-May-2016 A61B17/3468
To view Medautonomic’s complete patent history, request access »

Medautonomic Executive Team (4)

Name Title Board Seat Contact Info
Paolo Fabris Co-Founder & Co-Chief Executive Officer
Domenico Moro Co-Chief Executive Officer
Valerio Cigaina Co-Founder & President
John Gonzales Ph.D Co-Founder & Chief Economist
To view Medautonomic’s complete executive team members history, request access »

Medautonomic Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
QB3 Accelerator/Incubator Minority 000 0000 000000 0
Good Capital (India) Venture Capital Minority 000 0000 000000 0
To view Medautonomic’s complete investors history, request access »

Medautonomic FAQs

  • When was Medautonomic founded?

    Medautonomic was founded in 2013.

  • Who is the founder of Medautonomic?

    Paolo Fabris, Valerio Cigaina, and John Gonzales Ph.D are the founders of Medautonomic.

  • Who is the CEO of Medautonomic?

    Paolo Fabris and Domenico Moro are the CEOs of Medautonomic.

  • Where is Medautonomic headquartered?

    Medautonomic is headquartered in Concord, CA.

  • What industry is Medautonomic in?

    Medautonomic’s primary industry is Therapeutic Devices.

  • Is Medautonomic a private or public company?

    Medautonomic is a Private company.

  • What is Medautonomic’s current revenue?

    The current revenue for Medautonomic is 000000.

  • How much funding has Medautonomic raised over time?

    Medautonomic has raised $1.65M.

  • Who are Medautonomic’s investors?

    QB3 and Good Capital (India) have invested in Medautonomic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »